Emulsion compositions and methods of their use

Patent metadata

Field	Value
Publication number	US-2025250624-A1
Application number	US-202519095906-A
Country	US
Kind code	A1
Filing date	Mar 31, 2025
Priority date	Jan 30, 2017
Publication date	Aug 7, 2025
Grant date	—

Abstract

Emulsion compositions are provided herein. Also provided herein are kits containing one or more emulsion compositions or components for making such emulsion compositions. Also provided herein are methods of using such emulsion compositions, such as for amplification of target nucleic acids in emulsion droplets.

First claim

1 - 20 . (canceled)

21 . A method of using an emulsion comprising a water-in-oil emulsion droplet, the method comprising:
(a) providing the emulsion wherein water-in-oil emulsion droplet comprises:
water;
a plurality of cyclodextrin molecules; and
a plurality of amphiphilic polymer molecules, wherein individual amphiphilic polymer molecules of the plurality comprise a hydrophobic moiety and a hydrophilic moiety,
wherein at least a portion of the cyclodextrin molecules and the amphiphilic polymer molecules form a plurality of polypseudorotaxane complexes, and wherein the droplet is present in a continuous oil phase; (b) heating the droplet to a temperature of between about 50° C. to about 100° C.; (c) cooling the droplet to a temperature below about 50° C.; optionally repeating the heating and cooling between 1-50 times; and (d) after the cooling or the optionally repeated heating and cooling, the method further comprises injecting at least a portion of the droplet interior into a second droplet.

22 . The method of claim 21 , wherein the droplet comprises a target nucleic acid or an amplicon or reverse transcription product thereof.

23 . The method of claim 22 , wherein the second droplet comprises a detection reagent for detecting the presence or absence of the target nucleic acid or the amplicon or reverse transcription product thereof.

24 . The method of claim 23 , wherein the detection reagents are different in different second droplets injected with a portion of the first droplet, wherein the different detection reagents detect a presence or absence of a different target nucleic acid or of a different amplicon or reverse transcription product thereof.

25 . The method of claim 21 , wherein the emulsion comprises at least 1,000 water-in-oil emulsion droplets, and the method comprises:
providing the emulsion comprising the at least 1,000 water-in-oil emulsion droplets; heating the droplets to a temperature of between about 50° C. to about 100° C.; cooling the droplets to a temperature below about 50° C.; and optionally repeating the heating and cooling between 1-50 times.

26 . The method of claim 25 , wherein after the cooling or the optionally repeated heating and cooling, the method further comprises injecting at least a portion of the droplet interiors into a plurality of second droplets.

27 . The method of claim 21 , wherein the mass ratio of cyclodextrin molecules to amphiphilic polymer molecules in the droplet is from about 1:4 to about 4:1.

28 . The method of claim 21 , wherein individual cyclodextrin molecules of the plurality are independently selected from the group consisting of:
an α-cyclodextrin and a β-cyclodextrin; or an α-cyclodextrin and a γ-cyclodextrin; or a β-cyclodextrin, and a γ-cyclodextrin.

29 . The method of claim 21 , wherein at least some of the cyclodextrin molecules comprise 2-hydroxypropyl α-cyclodextrin, 2-hydroxypropyl β-cyclodextrin, or 2-hydroxypropyl γ-cyclodextrin.

30 . The method of claim 21 , wherein the amphiphilic polymer molecules comprise block co-polymers, wherein the block co-polymers comprise a hydrophilic block and a hydrophobic block.

31 . The method of claim 30 , wherein the block co-polymers are di-block co-polymers or tri-block co-polymers, or a combination thereof.

32 . The method of claim 31 , wherein the block co-polymers are di-block co-polymers comprising a polyethylene glycol (PEG) hydrophilic block and a hydrophobic block.

33 . The method of claim 31 , wherein the block co-polymers are di-block co-polymers comprising a hydrophilic block and a hydrophobic block comprising polypropylene glycol.

34 . The method of claim 31 , wherein the block co-polymers are tri-block co-polymers.

35 . The method of claim 34 , wherein the tri-block co-polymers are poloxamers.

36 . The method of claim 35 , wherein the poloxamers are poloxamer 188.

37 . The method of claim 21 , wherein the droplets are present in a continuous fluorocarbon oil phase.

38 . The method of claim 37 , wherein the continuous fluorocarbon oil phase comprises a fluorous oil and a surfactant.

39 . The method of claim 38 , wherein the surfactant is a fluorosurfactant.

40 . The method of claim 39 , wherein the fluorosurfactant is a block co-polymer comprising a perfluorinated polyether block and a polyethylene glycol block.

Assignees

• Bio Rad Laboratories Inc

Inventors

• Xue Yi
• Ritchey Joshua
• Meltzer Robert

Classifications

• C12Q1/6846 Primary

  Common amplification features · CPC title

• C12Q1/6816

  characterised by the detection means (C12Q1/6804 takes precedence) · CPC title

• C12Q2563/159

  Microreactors, e.g. emulsion PCR or sequencing, droplet PCR, microcapsules, i.e. non-liquid containers with a range of different permeability's for different reaction components · CPC title

• C12Q2527/125

  Specific component of sample, medium or buffer · CPC title

• C12Q1/686

  Polymerase chain reaction [PCR] · CPC title